- Home
- CCU vs CPRX Comparison
CCU vs CPRX Comparison
Compare CCU & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCU
- CPRX
- Stock Information
- Founded
- CCU 1850
- CPRX 2002
- Country
- CCU Chile
- CPRX United States
- Employees
- CCU N/A
- CPRX N/A
- Industry
- CCU Beverages (Production/Distribution)
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- CCU Consumer Staples
- CPRX Health Care
- Exchange
- CCU Nasdaq
- CPRX Nasdaq
- Market Cap
- CCU 2.4B
- CPRX 2.6B
- IPO Year
- CCU 1992
- CPRX 2006
- Fundamental
- Price
- CCU $12.52
- CPRX $20.07
- Analyst Decision
- CCU Strong Sell
- CPRX Strong Buy
- Analyst Count
- CCU 1
- CPRX 5
- Target Price
- CCU $9.40
- CPRX $33.20
- AVG Volume (30 Days)
- CCU 199.4K
- CPRX 1.4M
- Earning Date
- CCU 08-07-2025
- CPRX 08-06-2025
- Dividend Yield
- CCU 2.43%
- CPRX N/A
- EPS Growth
- CCU 38.53
- CPRX 183.96
- EPS
- CCU 0.44
- CPRX 1.65
- Revenue
- CCU $3,254,866,554.00
- CPRX $558,499,000.00
- Revenue This Year
- CCU $9.56
- CPRX $16.37
- Revenue Next Year
- CCU $4.52
- CPRX $8.80
- P/E Ratio
- CCU $14.45
- CPRX $12.18
- Revenue Growth
- CCU 19.82
- CPRX 28.55
- 52 Week Low
- CCU $10.03
- CPRX $19.00
- 52 Week High
- CCU $15.75
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- CCU 55.91
- CPRX 40.47
- Support Level
- CCU $11.58
- CPRX $19.36
- Resistance Level
- CCU $12.64
- CPRX $20.51
- Average True Range (ATR)
- CCU 0.33
- CPRX 0.74
- MACD
- CCU 0.13
- CPRX -0.06
- Stochastic Oscillator
- CCU 90.83
- CPRX 27.22
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).